Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tezacaftor/Ivacaftor Rollover Study in Cystic Fibrosis (6+ years)
NCT03537651Phase 3Completed
- Sponsor
- Vertex Pharmaceuticals
- Start
- Apr 2018
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 3 trial of tezacaftor, ivacaftor in cystic fibrosis (CF), sponsored by Vertex Pharmaceuticals. Started Apr 2018; status: completed.
02
Drugs
tezacaftorivacaftor
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT03537651.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03537651.